Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
American Journal of Clinical Oncology
|
October 1, 1987
Aminothiadiazole (NSC #4728) in patients with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology Group
R F Asbury, A Kramar, D G Haller
The Journal of Biological Chemistry
|
August 10, 1978
Soluble adenylate cyclase from thyroid membranes
R F Asbury, G H Cook, J Wolff
American Journal of Clinical Oncology
|
April 1, 1994
A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix
R F Asbury, J A Blessing, J T Soper
American Journal of Clinical Oncology
|
August 1, 1988
A phase II study of spirogermanium in advanced large bowel cancer. An Eastern Cooperative Oncology Group study
K J Pandya, A Kramar, R F Asbury, et al.
American Journal of Clinical Oncology
|
October 1, 1989
Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group
R F Asbury, J A Blessing, P J DiSaia, et al.
Seminars in Oncology
|
June 1, 1995
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide
L Boros, G C Garrow, R F Asbury, et al.
American Journal of Clinical Oncology
|
February 1, 1990
Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group
R F Asbury, J A Blessing, W P McGuire, et al.
Seminars in Oncology
|
June 1, 1996
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study
A Y Chang, L Boros, G C Garrow, et al.
Seminars in Oncology
|
June 1, 1995
Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer
A Y Chang, R F Asbury, L Boros, et al.
American Journal of Clinical Oncology
|
August 1, 1987
Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group
R F Asbury, J A Blessing, R Mortel, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
American Journal of Clinical Oncology
|
October 1, 1987
Aminothiadiazole (NSC #4728) in patients with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology Group
R F Asbury, A Kramar, D G Haller
The Journal of Biological Chemistry
|
August 10, 1978
Soluble adenylate cyclase from thyroid membranes
R F Asbury, G H Cook, J Wolff
American Journal of Clinical Oncology
|
April 1, 1994
A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix
R F Asbury, J A Blessing, J T Soper
American Journal of Clinical Oncology
|
August 1, 1988
A phase II study of spirogermanium in advanced large bowel cancer. An Eastern Cooperative Oncology Group study
K J Pandya, A Kramar, R F Asbury, et al.
American Journal of Clinical Oncology
|
October 1, 1989
Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group
R F Asbury, J A Blessing, P J DiSaia, et al.
Seminars in Oncology
|
June 1, 1995
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide
L Boros, G C Garrow, R F Asbury, et al.
American Journal of Clinical Oncology
|
February 1, 1990
Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group
R F Asbury, J A Blessing, W P McGuire, et al.
Seminars in Oncology
|
June 1, 1996
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study
A Y Chang, L Boros, G C Garrow, et al.
Seminars in Oncology
|
June 1, 1995
Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer
A Y Chang, R F Asbury, L Boros, et al.
American Journal of Clinical Oncology
|
August 1, 1987
Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group
R F Asbury, J A Blessing, R Mortel, et al.
Page
of 3